PE  Arsenal Capital Partners

     Office Locations:

100 Park Avenue, 31st Floor
New York, NY 10017
Phone: 212-771-1717
Fax: 212-771-1718

Get all office locations for this firm with a National Database subscription or New York Database subscription.


  • Middle Market



  • Business Services
  • Defense & Homeland Security
  • Financial Services
  • Life Sciences & Healthcare
  • Manufacturing & Industrial
  • Medical Device



    Arsenal Capital Partners, founded in 2000, is an industry-focused investor in middle-market niche products and services companies. The firm has $1.67 billion of committed capital under management and targets businesses across all sectors in the $50 to $250 million enterprise value range. In April 2013, Arsenal closed its third fund, Capital Partners III, with $875 million worth of commitments. The firm works closely with its portfolio companies by aggregating buying power and sharing best practices in procurement & supply chain, human capital, information technology, quality & six sigma, and program management. The firm focuses on the following end markets: Healthcare Pharmaceutical Services (Medical Devices, Healthcare Services); Specialty Industrial Specialty Chemicals & Materials (Aerospace Defense, Transportation & Logistics, Commercial / Industrial Services, Printing & Packaging); and Financial Services (Transaction Processing, Business Services, Financial Technology, Commercial & Consumer Finance, Insurance & Brokerage, Asset Management). Arsenal Capital Partners targets equity investments of $25 to $75 million in each portfolio company. Arsenal has an additional office in Shanghai, China.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Jeffrey Kovach Partner
    Joelle Marquis Partner
    John Televantos Partner
    Stephen McLean Partner
    Terence Mullen Partner


    Portfolio companies include:

      Aptimmune Biologics
        web link

        web link

      Breckenridge Insurance
        web link

      Charter Brokerage
        web link

      Chromaflo Technologies
        web link

      Dash Multi-Corp
        web link

        web link

        web link

      FrontStream Payments
        web link

        web link

      KGS-Alpha Capital Markets
        web link

      Novolyte Technologies
        web link

        web link

      Royal Adhesives & Sealants
        web link

      Source Refrigeration & HVAC
        web link

      Tempo Financial Holdings
        web link

      Velsicol Chemical
        web link

        web link


    Recent News: